MedTrace Logo

Prospective Collection of Samples for Urothelial Cancer of Bladder

NCT04167332 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 630

Last updated 2019-11-18

No results posted yet for this study

Summary

ProCSUCaB (Prospective Collection of Samples for Urothelial Cancer of Bladder) is a monocentric, non-interventional, prospective registry that will recruit newly diagnosed intermediate- and high-risk NMIBC patients in a tertiary center in Flanders.

Conditions

Sponsors & Collaborators

  • KU Leuven

    collaborator OTHER

  • HistoGeneX

    collaborator UNKNOWN

  • MDx Health

    collaborator INDUSTRY

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Mosaiques Diagnostics and Therapeutics AG

    collaborator UNKNOWN

  • Biomedical Research Foundation, Academy of Athens

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Steven Joniau, MD, PhD · UZ Leuven

  • Frank Van Der Aa, MD, PhD · UZ Leuven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-31
Primary Completion
2024-12-31
Completion
2029-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167332 on ClinicalTrials.gov